Pankaj Kumar, Ali Mousavi, and Hans Frykman. Antibody Testing for Autoimmune Neurological Disorders: Which Test/s to Order and Why? AACC Academy Scientific Shorts. November 22, 2022, Available from:
Frykman, H, Kumar, P.  An Opinion on the Clinical Laboratory Testing following the New 2021 PNS-Care Diagnostic Criteria, The Journal of Applied Laboratory Medicine, Volume 7, Issue 1, January 2022, Pages 367–372,
Frykman, H, Kumar, P.  Laboratory Testing of Myasthenia Gravis: New Treatments Drive Change, The Journal of Applied Laboratory Medicine, , jfaa199,
Frykman, H, Kumar, P, Oger, J.  Immunopathology of Autoimmune Myasthenia Gravis: Implications for Improved Testing Algorithms and Treatment Strategies.  Front. Neurol., 09 December 2020 |
Oger J, Frykman H. 2015 Sep 20;449:43-8.  doi:10.1016/j.cca.2015.07.030.
Fronda A, Gibbs E, Aziz T, Oger J (2014).  Detection Of Anti-Natalizumab Antibodies In Treated Multiple Sclerosis Patients Using a Biacore™ Platform (P4.139).  
Fronda A, Kuan A, Fritzler M, Fujihara K, Takahashi T. (2012). NMO-IgG as Measured in Multiple Facilities in Optic Neuritis (ON), Transverse Myelitis (TM) and Combinations Thereof (P02.130). Neurology. 78. P02.130-P02.130. 10.1212/WNL.78.1_MeetingAbstracts.P02.130.
Spagni G, Gastaldi M, Businaro P, Chemkhi Z, Carrozza C, Mascagna G, Falso S, Scaranzin S, Franciotta D, Evoli A, Damato V. Comparison of Fixed and Live Cell-Based Assay for the Detection of AChR and MuSK Antibodies in Myasthenia Gravis. Neurology-Neuroimmunology Neuroinflammation. 2023 Jan 1;10(1). Available from:
Waters PJ, Komorowski L, Woodhall M, et al. A multicenter comparison of MOG-IgG cell-based assays. Neurology. 2019;92(11):e1250‐e1255. doi:10.1212/WNL.0000000000007096
Pittock SJ, Berthele A, Fujihara K, et al. Eculizumab in Aquaporin-4-Positive Neuromyelitis Optica Spectrum Disorder. N Engl J Med. 2019;381(7):614‐625. doi:10.1056/NEJMoa1900866
Yeh EA, Nakashima I. Live-cell based assays are the gold standard for anti-MOG-Ab testing. Neurology. 2019;92(11):501‐502. doi:10.1212/WNL.0000000000007077
Jarius S, Paul F, Aktas O, et al. MOG encephalomyelitis: international recommendations on diagnosis and antibody testing. J Neuroinflammation. 2018;15(1):134. Published 2018 May 3. doi:10.1186/s12974-018-1144-2
Waters P, Reindl M, Saiz A, et al. Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica. J Neurol Neurosurg Psychiatry. 2016;87(9):1005‐1015. doi:10.1136/jnnp-2015-312601
Rodríguez Cruz PM, Al-Hajjar M, Huda S, et al. Clinical Features and Diagnostic Usefulness of Antibodies to Clustered Acetylcholine Receptors in the Diagnosis of Seronegative Myasthenia Gravis. JAMA Neurol. 2015;72(6):642‐649. doi:10.1001/jamaneurol.2015.0203
Waters PJ, Pittock SJ, Bennett JL, Jarius S, Weinshenker BG, Wingerchuk DM. Evaluation of aquaporin-4 antibody assays. Clin Exp Neuroimmunol. 2014;5(3):290‐303. doi:10.1111/cen3.12107
Chang T, Leite MI, Senanayake S, et al. Clinical and serological study of myasthenia gravis using both radioimmunoprecipitation and cell-based assays in a South Asian population. J Neurol Sci. 2014;343(1-2):82-87. doi:10.1016/j.jns.2014.05.037
Alkhawajah NM, Oger J. Muscle Nerve. 2013 Nov;48(5):705-10. doi: 10.1002/mus.23964.